Immune responses and vaccine-induced immunity against Porcine circovirus type 2

Veterinary Immunology and Immunopathology

Volumn 136, Issue 3-4, 2010, Pages 185-193

  Kekarainen, T ^a   McCullough, K ^b   Fort, M ^a   Fossum, C ^c   Segales J ^a,d   Allan, G M ^e  

^a CENTRE DE RECERCA EN SANITAT ANIMAL CRESA   (Spain)

^b INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (Switzerland)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Immunology; Porcine circovirus; Porcine circovirus diseases (PCVD); Vaccine

Indexed keywords

CIRCOFLEX; CIRCOVAC; CIRCUMVENT; PCV; PORCINE CIRCOVIRUS TYPE 2 VACCINE; SUVAXYN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS VACCINE;

ANTIBODY RESPONSE; ANTIVIRAL ACTIVITY; CELLULAR IMMUNITY; CIRCOVIRUS; DENDRITIC CELL; DRUG EFFICACY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PORCINE CIRCOVIRUS TYPE 2; REVIEW; VACCINATION; VIRUS INFECTION; ANIMAL; ANIMAL DISEASE; CIRCOVIRIDAE INFECTION; IMMUNOLOGY; POSTWEANING MULTISYSTEMIC WASTING SYNDROME; STANDARD; SWINE; VIROLOGY;

ANIMALIA; PORCINE CIRCOVIRUS; PORCINE CIRCOVIRUS 2; SUIDAE;

ANIMALS; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; DENDRITIC CELLS; DNA, VIRAL; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; MACROPHAGES; MONOCYTES; PORCINE POSTWEANING MULTISYSTEMIC WASTING SYNDROME; SWINE; VIRAL VACCINES;

EID: 77958196886     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2010.03.025     Document Type: Review

References (97)

1. Allan G.M., Ellis J.A. Porcine circoviruses: a review. J. Vet. Diagn. Invest. 2000, 12:3-14.
2. Allan G.M., Kennedy S., McNeilly F., Foster J.C., Ellis J.A., Krakowka S.J., Meehan B.M., Adair B.M. Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus. J. Comp. Pathol. 1999, 121:1-11.
3. An D.J., Song D.S., Park B.K. Systemic cytokine profiles of mice vaccinated with naked DNAs encoding six open reading frame antigens of porcine circovirus type 2 (PCV2). Res. Vet. Sci. 2008, 85:503-509.
4. Aravindaram K., Kuo T.Y., Lan C.W., Yu H.H., Wang P.H., Chen Y.S., Chen G.H., Yang N.S. Protective immunity against porcine circovirus 2 in mice induced by a gene-based combination vaccination. J. Gene Med. 2009, 11:288-301.
5. Balasch M., Segales J., Rosell C., Domingo M., Mankertz A., Urniza A., Plana-Duran J. Experimental inoculation of conventional pigs with tissue homogenates from pigs with post-weaning multisystemic wasting syndrome. J. Comp. Pathol. 1999, 121:139-148.
6. Blanchard P., Mahe D., Cariolet R., Keranflec'h A., Baudouard M.A., Cordioli P., Albina E., Jestin A. Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins. Vaccine 2003, 21:4565-4575.
7. Blanchard P., Mahe D., Cariolet R., Truong C., Le Dimna M., Arnauld C., Rose N., Eveno E., Albina E., Madec F., Jestin A. An ORF2 protein-based ELISA for porcine circovirus type 2 antibodies in post-weaning multisystemic wasting syndrome. Vet. Microbiol. 2003, 94:183-194.
8. Bolin S.R., Stoffregen W.C., Nayar G.P., Hamel A.L. Postweaning multisystemic wasting syndrome induced after experimental inoculation of cesarean-derived, colostrum-deprived piglets with type 2 porcine circovirus. J. Vet. Diagn. Invest. 2001, 13:185-194.
9. Calsamiglia M., Fraile L., Espinal A., Cuxart A., Seminati C., Martín M., Mateu E., Domingo M., Segalés J. Sow porcine circovirus type 2 (PCV2) status effect on litter mortality in postweaning multisystemic wasting syndrome (PMWS). Res. Vet. Sci. 2007, 82:299-304.
10. Carrasco C.P., Rigden R.C., Vincent I.E., Balmelli C., Ceppi M., Bauhofer O., Tâche V., Hjertner B., McNeilly F., van Gennip H.G., McCullough K.C., Summerfield A. Interaction of classical swine fever virus with dendritic cells. J. Gen. Virol. 2004, 85:1633-1641.
11. Carrasco L., Segales J., Bautista M.J., Gomez-Villamandos J.C., Rosell C., Ruiz-Villamor E., Sierra M.A. Intestinal chlamydial infection concurrent with postweaning multisystemic wasting syndrome in pigs. Vet. Rec. 2000, 146:21-23.
12. Clark E. Postweaning Multisystemic Wasting Syndrome 1997, American Association of Swine Practitioners, Quebec City, Canada, pp. 499-501.
13. Chang H.-W., Jeng C.-R., Lin T.-L., Liu J.J., Chiou M.-T., Tsai C.Y., Chia M.-Y., Jan T.-R., Pang V.F. Immunopathological effects of porcine circovirus type 2 (PCV2) on swine alveolar macrophages by in vitro inoculation. Vet. Immunol. Immunopathol. 2006, 110:207-219.
14. Chang H.-W., Jeng C.-R., Liu J.J., Lin T.-L., Chang C.-C., Chia M.-Y., Tsai C.Y., Pang V.F. Reduction of porcine reproductive and respiratory syndrome virus (PRRSV) infection in swine alveolar macrophages by porcine circovirus 2 (PCV2)-induced interferon alpha. Vet. Microbiol. 2005, 108:167-177.
15. Chianini F., Majo N., Segales J., Dominguez J., Domingo M. Immunohistochemical characterisation of PCV2 associate lesions in lymphoid and non-lymphoid tissues of pigs with natural postweaning multisystemic wasting syndrome (PMWS). Vet. Immunol. Immunopathol. 2003, 94:63-75.
16. Cline G., Wilt V., Diaz E., Edler R. Efficacy of immunising pigs against porcine circovirus type 2 at three or six weeks of age. Vet. Rec. 2008, 163:737-740.
17. Darwich L., Balasch M., Plana-Duran J., Segales J., Domingo M., Mateu E. Cytokine profiles of peripheral blood mononuclear cells from pigs with postweaning multisystemic wasting syndrome in response to mitogen, superantigen or recall viral antigens. J. Gen. Virol. 2003, 84:3453-3457.
18. Darwich L., Pie S., Rovira A., Segales J., Domingo M., Oswald I.P., Mateu E. Cytokine mRNA expression profiles in lymphoid tissues of pigs naturally affected by postweaning multisystemic wasting syndrome. J. Gen. Virol. 2003, 84:2117-2125.
19. Darwich L., Segales J., Domingo M., Mateu E. Changes in CD4(+), CD8(+), CD4(+) CD8(+), and immunoglobulin M-positive peripheral blood mononuclear cells of postweaning multisystemic wasting syndrome-affected pigs and age-matched uninfected wasted and healthy pigs correlate with lesions and porcine circovirus type 2 load in lymphoid tissues. Clin. Diagn. Lab. Immunol. 2002, 9:236-242.
20. Darwich L., Segales J., Mateu E. Pathogenesis of postweaning multisystemic wasting syndrome caused by Porcine circovirus 2: an immune riddle. Arch. Virol. 2004, 149:857-874.
21. Desrosiers R., Clark E., Tremblay D., Tremblay R., Polson D. Use of a one-dose subunit vaccine to prevent losses associated with porcine circovirus type 2. J. Swine Health Prod. 2009, 17:148-154.
22. Ellis J., Clark E., Haines D., West K., Krakowka S., Kennedy S., Allan G.M. Porcine circovirus-2 and concurrent infections in the field. Vet. Microbiol. 2004, 98:159-163.
23. Fachinger V., Bischoff R., Jedidia S.B., Saalmuller A., Elbers K. The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex. Vaccine 2008, 26:1488-1499.
24. Fan H., Pan Y., Fang L., Wang D., Wang S., Jiang Y., Chen H., Xiao S. Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice. J. Virol. Methods 2008, 150:21-26.
25. Fan H., Xiao S., Tong T., Wang S., Xie L., Jiang Y., Chen H., Fang L. Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments. Mol. Immunol. 2008, 45:653-660.
26. Fenaux M., Opriessnig T., Halbur P.G., Elvinger F., Meng X.J. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs. J. Virol. 2004, 78:6297-6303.
27. Fenaux M., Opriessnig T., Halbur P.G., Meng X.J. Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs. J. Virol. 2003, 77:11232-11243.
28. Fort M., Fernandes L.T., Nofrarias M., Díaz I., Sibila M., Pujols J., Mateu E., Segalés J. Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in caesarean-derived, colostrum-deprived piglets. Vet. Immunol. Immunopathol. 2009, 129:101-107.
29. Fort M., Olvera A., Sibila M., Segalés J., Mateu E. Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs. Vet. Microbiol. 2007, 125:244-255.
30. Fort M., Sibila M., Allepuz A., Mateu E., Roerink F., Segalés J. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Vaccine 2008, 26:1063-1071.
31. Fort M., Sibila M., Pérez-Martín E., Nofrarías M., Mateu E., Segalés J. One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model. Vaccine 2009, 27:4031-4037.
32. Gilpin D.F., Mc Cullough K.C., Meehan B., McNeilly F., McNair I., Stevenson L.S., Foster J.C., Ellis J., Krakowa S., Adair B., Allan G. In vitro studies on the infection and replication of porcine circovirus type 2 in cells of the porcine immune system. Vet. Immunol. Immunopathol. 2003, 94:149-161.
33. Goubier A., Chapat L., Toma S., Piras F., Joisel F., Maurin-Bernaud L., Charreyre C., Andreoni C., Juillard V. Transfer of maternal immunity from sows vaccinated against PCV2 with Circovac to their piglets. Proceedings of the 18th IPVS Congress, vol. 1 2008, 16.
34. Grau-Roma L., Hjulsager C.K., Sibila M., Kristensen C.S., López-Soria S., Enøe C., Casal J., Bøtner A., Nofrarías M., Bille-Hansen V., Fraile L., Baekbo P., Segalés J., Larsen L.E. Infection, excretion and seroconversion dynamics of porcine circovirus type 2 (PCV2) in pigs from post-weaning multisystemic wasting syndrome (PMWS) affected farms in Spain and Denmark. Vet. Microbiol. 2009, 135:272-282.
35. Hasslung F., Wallgren P., Ladekjaer-Hansen A.S., Botner A., Nielsen J., Wattrang E., Allan G.M., McNeilly F., Ellis J., Timmusk S., Belak K., Segall T., Melin L., Berg M., Fossum C. Experimental reproduction of postweaning multisystemic wasting syndrome (PMWS) in pigs in Sweden and Denmark with a Swedish isolate of porcine circovirus type 2. Vet. Microbiol. 2005, 106:49-60.
36. Hasslung Wikström F., Berg M., Allan G., Meehan B., Mc Neilly F., Fossum C. Identification of a sequence from the genome of porcine circovirus type 2 with an inhibitory effect on IFN-a production by porcine PBMCs. J. Gen. Virol. 2003, 84:2937-2945.
37. Horlen K.P., Dritz S.S., Nietfeld J.C., Henry S.C., Hesse R.A., Oberst R., et al. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2. J. Am. Vet. Med. Assoc. 2008, 232:906-912.
38. Ju C., Fan H., Tan Y., Liu Z., Xi X., Cao S., Wu B., Chen H. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2. Vet. Microbiol. 2005, 109:179-190.
39. Kamstrup S., Barfoed A.M., Frimann T.H., Ladekjaer-Mikkelsen A.S., Botner A. Immunisation against PCV2 structural protein by DNA vaccination of mice. Vaccine 2004, 22:1358-1361.
40. Kekarainen T., Montoya M., Dominguez J., Mateu E., Segalés J. Porcine circovirus type 2 (PCV2) viral components immunomodulate recall antigen responses. Vet. Immunol. Immunopathol. 2008, 124:41-49.
41. Kekarainen T., Montoya M., Mateu E., Segalés J. Porcine circovirus type 2-induced interleukin-10 modulates recall antigen responses. J. Gen. Virol. 2008, 89:760-765.
42. Kim J., Chae C. Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 in porcine circovirus 2-induced granulomatous inflammation. J. Comp. Pathol. 2004, 131:121-126.
43. Kixmöller M., Ritzmann M., Eddicks M., Saalmüller A., Elbers K., Fachinger V. Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2. Vaccine 2008, 26:3443-3451.
44. Krakowka S., Ellis J., McNeilly F., Gilpin D.F., Meehan B., McCullough K.C., Allan G. Immunologic features of porcine circovirus type 2 infection. Viral Immunol. 2002, 15:567-582.
45. Krakowka S., Ellis J.A., McNeilly F., Ringler S., Rings D.M., Allan G. Activation of the immune system is the pivotal event in the production of wasting disease in pigs infected with porcine circovirus-2 (PCV-2). Vet. Pathol. 2001, 38:31-42.
46. Ladekjaer-Mikkelsen A.-S., Nielsen J., Stadejek T., Storgaard T., Krakowka S., Ellis J., McNeilly F., Allan G., Botner A. Reproduction of postweaning multisystemic wasting syndrome (PMWS) in immunostimulated and non-immunostimulated 3-week-old piglets experimentally infected with porcine circovirus type 2 (PCV2). Vet. Microbiol. 2002, 89:97-114.
47. Larochelle R., Magar R., D'Allaire S. Comparative serologic and virologic study of commercial swine herds with and without postweaning multisystemic wasting syndrome. Can. J. Vet. Res. 2003, 67:114-120.
48. Liu Q., Willson P., Attoh-Poku S., Babiuk L.A. Bacterial expression of an immunologically reactive PCV2 ORF2 fusion protein. Protein Express. Purif. 2001, 21:115-120.
49. Madec F., Rose N., Grasland B., Cariolet R., Jestin A. Post-weaning multisystemic wasting syndrome and other PCV2-related problems in pigs: a 12-year experience. Transbound. Emerg. Dis. 2008, 55:273-283.
50. Madson D.M., Patterson A.R., Ramamoorthy S., Pal N., Meng X.J., Opriessnig T. Effect of porcine circovirus type 2 (PCV2) vaccination of the dam on PCV2 replication in utero. Clin. Vac. Immunol. 2009.
51. McCullough K.C., Summerfield A. Targeting the porcine immune system-particulate vaccines in the 21st century. Dev. Comp. Immunol. 2009, 33:394-409.
52. McNeilly F., Allan G., Foster J.C., Adair B., McNulty M.S. Effect of porcine circovirus infection on porcine alveolar macrophage function. Vet. Immunol. Immunopathol. 1996, 49:295-306.
53. Meerts P., Misinzo G., Lefebvre D., Nielsen J., Botner A., Kristensen C.S., Nauwynck H.J. Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease. BMC Vet. Res. 2006, 2:6.
54. Meerts P., Van Gucht S., Cox E., Vandebosch A., Nauwynck H. Correlation between type of adaptive immune response against porcine circovirus type 2 and level of virus replication. Viral Immunol. 2005, 18:333-341.
55. Nielsen J., Vincent I.E., Botner A., Ladekaer-Mikkelsen A.S., Allan G., Summerfield A., McCullough K.C. Association of lymphopenia with porcine circovirus type 2 induced postweaning multisystemic wasting syndrome (PMWS). Vet. Immunol. Immunopathol. 2003, 92:97-111.
56. Nunez A., McNeilly F., Perea A., Sanchez-Cordon P.J., Huerta B., Allan G., Carrasco L. Coinfection by Cryptosporidium parvum and porcine circovirus type 2 in weaned pigs. J. Vet. Med. B Infect. Dis. Vet. Public Health 2003, 50:255-258.
57. Okuda Y., Ono M., Yazawa S., Shibata I. Experimental reproduction of postweaning multisystemic wasting syndrome in cesarean-derived, colostrum-deprived piglets inoculated with porcine circovirus type 2 (PCV2): investigation of quantitative PCV2 distribution and antibody responses. J. Vet. Diagn. Invest. 2003, 15:107-114.
58. Opriessnig T., Meng X.-J., Halbur P.G. Porcine Circovirus Type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. J. Vet. Diagn. Invest. 2007, 19:591-615.
59. Opriessnig T., Patterson A.R., Madson D.M., Pal N., Halbur P.G. Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination. Vaccine 2009, 27:1002-1007.
60. Ostanello F., Caprioli A., Di Francesco A., Battilani M., Sala G., Sarli G., Mandrioli L., McNeilly F., Allan G.M., Prosperi S. Experimental infection of 3-week-old conventional colostrum-fed pigs with porcine circovirus type 2 and porcine parvovirus. Vet. Microbiol. 2005, 108:179-186.
61. Pan Q., He K., Huang K. Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2. Vaccine 2008, 26:2119-2126.
62. Pejsak Z., Podgórska K., Truszczyński M., Karbowiak P., Stadejek T. Efficacy of different protocols of vaccination against porcine circovirus type 2 (PCV2) in a farm affected by postweaning multisystemic wasting syndrome (PMWS). Comp. Immunol. Microbiol. Infect. Dis. 2009, 10.1016/j.cimid.2009.09.006.
63. Pérez-Martín E., Gómez-Sebastián S., Argilaguet J.M., Sibila M., Fort M., Nofrarías M., Kurtz S., Escribano J.M., Segalés J., Rodríguez F. Immunity conferred by an experimental vaccine based on the recombinant PCV2 Cap protein expressed in Trichoplusia ni-larvae. Vaccine 2010, 28:2340-2349.
64. Pérez-Martín E., Grau-Roma L., Argilaguet J.M., Nofrarías M., Escribano J.M., Gómez-Sebastián S., Segalés J., Rodríguez F. Development of two Trichoplusia ni larvae-derived ELISAs for the detection of antibodies against replicase and capsid proteins of porcine circovirus type 2 in domestic pigs. J. Virol. Met. 2008, 154:167-174.
65. Pérez-Martín E., Rovira A., Calsamiglia M., Mankertz A., Rodriguez F., Segales J. A new method to identify cell types that support porcine circovirus type 2 replication in formalin-fixed, paraffin-embedded swine tissues. J. Virol. Methods 2007, 146:86-95.
66. Pogranichniy R.M., Yoon K.J., Yaeger M., Vaughn E., Harmon K., Stammer R., Roof M. Possible prevention of PMWS using inactivated PCV2 vaccine in CDCD pigs. Proceedings of the 18th IPVS Congress, vol. 1 2004.
67. Pogranichnyy R.M., Yoon K.J., Harms P.A., Swenson S.L., Zimmerman J.J., Sorden S.D. Characterization of immune response of young pigs to porcine circovirus type 2 infection. Viral Immunol. 2000, 13:143-153.
68. Ramamoorthy S., Meng X.-J. Porcine circoviruses: a minuscule yet mammoth paradox. Anim. Health Res. Rev. 2009, 10:1-20.
69. Rodriguez-Arrioja G.M., Segales J., Calsamiglia M., Resendes A.R., Balasch M., Plana-Duran J., Casal J., Domingo M. Dynamics of porcine circovirus type 2 infection in a herd of pigs with postweaning multisystemic wasting syndrome. Am. J. Vet. Res. 2002, 63:354-357.
70. Rose N., Blanchard P., Larour G., Le Diguerher G., Eveno E., Jolly J., Oler A., Le Dimna M., Jestin A., Madec F. Post-weaning multisystemic wasting syndrome (PMWS) in France: serological profiles of affected versus non-affected herds and preliminary analytical epidemiology. Pig J. 2002, 50:124-134.
71. Rosell C., Segales J., Plana-Duran J., Balasch M., Rodriguez-Arrioja G.M., Kennedy S., Allan G.M., McNeilly F., Latimer K.S., Domingo M. Pathological, immunohistochemical, and in-situ hybridization studies of natural cases of postweaning multisystemic wasting syndrome (PMWS) in pigs. J. Comp. Pathol. 1999, 120:59-78.
72. Rovira A., Balasch M., Segales J., Garcia L., Plana-Duran J., Rosell C., Ellerbrok H., Mankertz A., Domingo M. Experimental inoculation of conventional pigs with porcine reproductive and respiratory syndrome virus and porcine circovirus 2. J. Virol. 2002, 76:3232-3239.
73. Sanchez Jnr R.E., Meerts P., Nauwynck H.J., Ellis J., Pensaert M. Characteristics of porcine circovirus-2 replication in lymphoid organs of pigs inoculated in late gestation or postnatally and possible relation to clinical and pathological outcome of infection. J. Vet. Diagn. Invest. 2004, 16:175-185.
74. Sarli G., Mandrioli L., Laurenti M., Sidoli L., Cerati C., Rolla G., Marcato P.S. Immunohistochemical characterisation of the lymph node reaction in pig post-weaning multisystemic wasting syndrome (PMWS). Vet. Immunol. Immunopathol. 2001, 83:53-67.
75. Segalés J. Update on postweaning multisystemic wasting syndrome and porcine dermatitis and nephropathy syndrome diagnostics. J. Swine Health Prod. 2002, 10.
76. Segalés J., Allan G.M., Domingo M. Porcine circovirus diseases. Anim. Health Res. Rev. 2005, 6:119-142.
77. Segalés J., Domingo M., Collelle M., Jensen H., Blanco J.L. Pulmonary Aspergillosis in a post-weaning multisystemic wasting syndrome (PMWS) affected pig. Pig J. 2003, 52:41-47.
78. Segalés J., Domingo M., Chianini F., Majo N., Dominguez J., Darwich L., Mateu E. Immunosuppression in postweaning multisystemic wasting syndrome affected pigs. Vet. Microbiol. 2004, 98:151-158.
79. Segalés J., Pastor J., Cuenca R., Domingo M. Haematological parameters in postweaning multisystemic wasting syndrome-affected pigs. Vet. Rec. 2000, 146:675-676.
80. Segalés J., Rosell C., Domingo M. Pathological findings associated with naturally acquired porcine circovirus type 2 associated disease. Vet. Microbiol. 2004, 98:137-149.
81. Segalés J., Urniza A., Alegre A., Bru T., Crisci E., Nofrarías M., López-Soria S., Balasch M., Sibila M., Xu Z., Chu H.J., Fraile L., Plana-Duran J. A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms. Vaccine 2009, 27:7313-7321.
82. Shang S.-B., Jin Y.-L., Jiang X.-t., Zhou J.-Y., Zhang X., Xing G., He J.L., Yan Y. Fine mapping of antigenic epitopes on capsid proteins of porcine circovirus, and antigenic phenotype of porcine circovirus Type 2. Mol. Immunol. 2009, 46:327-334.
83. Shen H.G., Zhou J.Y., Huang Z.Y., Guo J.Q., Xing G., He J.L., Yan Y., Gong L.Y. Protective immunity against porcine circovirus 2 by vaccination with ORF2-based DNA and subunit vaccines in mice. J. Gen. Virol. 2008, 89:1857-1865.
84. Shibahara T., Sato K., Ishikawa Y., Kadota K. Porcine circovirus induces B lymphocyte depletion in pigs with wasting disease syndrome. J. Vet. Med. Sci. 2000, 62:1125-1131.
85. Sibila M., Calsamiglia M., Segales J., Blanchard P., Badiella L., Le Dimna M., Jestin A., Domingo M. Use of a polymerase chain reaction assay and an ELISA to monitor porcine circovirus type 2 infection in pigs from farms with and without postweaning multisystemic wasting syndrome. Am. J. Vet. Res. 2004, 65:88-92.
86. Sipos W., Duvigneau J.C., Willheim M., Schilcher F., Hartl R.T., Hofbauer G., Exel B., Pietschmann P., Schmoll F. Systemic cytokine profile in feeder pigs suffering from natural postweaning multisystemic wasting syndrome (PMWS) as determined by semiquantitative RT-PCR and flow cytometric intracellular cytokine detection. Vet. Immunol. Immunopathol. 2004, 99:63-71.
87. Steiner E., Balmelli C., Gerber H., Summerfield A., McCullough K.C. Cellular adaptive immune response against porcine circovirus type 2 in subclinically infected pigs. BMC Vet. Res. 2009, 5:45.
88. Stevenson L.S., McCullough K., Vincent I., Gilpin D.F., Summerfield A., Nielsen J., McNeilly F., Adair B.M., Allan G.M. Cytokine and C-reactive protein profiles induced by porcine circovirus type 2 experimental infection in 3-week-old piglets. Viral Immunol. 2006, 19:189-195.
89. Tomás A., Fernandes L.T., Valero O., Segalés J. A meta-analysis on experimental infections with porcine circovirus type 2 (PCV2). Vet. Microbiol. 2008, 132:260-273.
90. Villa T. PCV2 and reproductive performance: facts and figures for the disbelievers. Merial Symposium. 18th IPVS 2008.
91. Vincent I.E., Balmelli C., Meehan B., Allan G., Summerfield A., McCullough K.C. Silencing of natural interferon producing cell activation by porcine circovirus type 2 DNA. Immunology 2007, 120:47-56.
92. Vincent I.E., Carrasco C.P., Guzylack-Piriou L., Herrmann B., McNeilly F., Allan G., Summerfield A., McCullough K.C. Subset-dependent modulation of dendritic cell activity by circovirus type 2. Immunology 2005, 115:388-398.
93. Vincent I.E., Carrasco C.P., Herrmann B., Meehan B., Allan G. Dendritic cells harbour infectious PCV2 in the absence of apparent modulation of the cells or replication of the virus. J. Virol. 2003, 77:13288-13300.
94. Wang K., Huang L., Kong J., Zhang X. Expression of the capsid protein of porcine circovirus type 2 in Lactococcus lactis for oral vaccination. J. Virol. Methods 2008, 150:1-6.
95. Wang X., Jiang P., Li Y., Jiang W., Dong X. Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2. Vet. Microbiol. 2007, 121:215-224.
96. Wikstrom F.H., Meehan B., Berg M., Timmusk S., Elving J., Fuxler L., Magnusson M.K., Allan G., McNeilly F., Fossum C. Structure-dependent modulation of alpha interferon production by porcine circovirus 2 oligodeoxyribonucleotide and CpG DNAs in porcine peripheral blood mononuclear cells. J. Virol. 2007, 81:4919-4927.
97. Yu S., Vincent A., Opriessnig T., Carpenter S., Kitikoon P., Halbur P.G., Thacker E. Quantification of PCV2 capsid transcript in peripheral blood mononuclear cells (PBMCs) in vitro. Vet. Microbiol. 2007, 123:34-42.